1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > US Personalized Cancer Genome Sequencing Market

The US personalized cancer Genome Sequencing market is primarily classified into Targeted Genome Sequencing and Whole-Genome Sequencing. Our report entitled “US Personalized Cancer Genome Sequencing Market” takes into account the Whole-Genome Sequencing services, which is one of the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment.

In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome Sequencing market, our report has effectively studied the current and future status of cancer in the US as well as its States. In view of the fact that cancer affects some specific age groups in a significant manner, we have also investigated the age-wise statistics of the disease. To get proper insight into the market, an in-depth analysis into the high-income group population is provided so that players can have a clear picture about their potential customer base and the market to be tapped.

The WGS industry has evolved in US in the recent times, and the level and seriousness of implementation has seen drastic changes. An in-depth study of the regulatory environment governing the US personalized cancer Whole-Genome Sequencing market has also been provided. It has been found that regulations related to personalized cancer sequencing are primarily governed with the accreditation of the laboratories performing the sequencing services and analysis, and also the usage of FDA approved tests for conducting these tests. Further, we have also discussed the various constraints faced by the industry players with suitable suggestions to overcome them.

The report analyzes the competitive landscape in the market by properly analyzing the business, services and activities of the companies. It also provides the competitive benchmarking, taking into account the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for the clients who want to get an in-depth understanding of the market.

Table Of Contents

US Personalized Cancer Genome Sequencing Market
1. Analyst View
2. Research Methodology
3. Cancer Statistics by Demographics
3.1 Prevalence, Incidences, and Mortality (2009-2017)
3.2 Leading States by Incidence
3.3 Leading Cancers by Incidence
3.3.1 Male Cancer Incidences
3.3.2 Female Cancer Incidences
3.3.3 Age-Group
4. US Personalized Cancer WGS Potential Market
5. US Personalized Cancer WGS: Current and Future Market Analysis
6. Regulatory Insights
6.1 Clinical Laboratory Improvement Amendments (CLIA) Accreditation
6.2 CAP Accreditation
7. Market Constraints
8. Competitive Assessment
8.1 Illumina
8.1.1 Business Overview
8.1.2 Strengths and Weaknesses
8.2 Complete Genomics
8.2.1 Business Overview
8.2.2 Strengths and Weaknesses
8.3 Beckman Coulter Genomics
8.3.1 Business Overview
8.3.2 Strengths and Weaknesses
8.4 Expression Analysis
8.4.1 Business Overview
8.4.2 Strengths and Weaknesses
8.5 EdgeBio
8.5.1 Business Overview
8.5.2 Strengths and Weaknesses
8.6 Foundation Medicine
8.6.1 Business Overview
8.6.2 Strengths and Weaknesses
8.7 SeqWright
8.7.1 Business Overview
8.7.2 Strengths and Weaknesses
8.8 Ambry Genetics
8.8.1 Business Overview
8.8.2 Strengths and Weaknesses
8.9 BGI Americas Corporation
8.9.1 Business Overview
8.9.2 Strengths and Weaknesses
8.10 Cofactor Genomics
8.10.1 Business Overview
8.10.2 Strengths and Weaknesses

List of Figures:

Figure 3-1: Cancer Prevalence (Million), 2009-2017
Figure 3-2: Cancer Incidences (‘000), 2009-2017
Figure 3-3: Cancer Mortality (‘000), 2009-2017
Figure 3-4: Incidences by Type of Cancer (%), 2013
Figure 3-5: Top Five States with Highest Cancer Incidences (‘000), 2013
Figure 3-6: Cancer Incidences by Age Group (%)
Figure 4-1: Potential Customers for Personalized Cancer WGS Market (‘000), 2012-2017
Figure 4-2: Potential Customers for Personalized Cancer WGS Market by Age-Group (%), 2013
Figure 4-3: Potential Market for Personalized Cancer WGS (Billion US$), 2012-2017
Figure 5-1: Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 5-2: Personalized Cancer WGS Market (Million US$), 2012-2017

List of Tables:

Table 3-1: Top 10 Cancer Incidences in Males (2013)
Table 3-2: Top 10 Cancer Incidences in Females (2013)
Table 4-1: Key Demographics and Potential Customers for Personalized Cancer WGS Market (2012)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
RNA Sequencing: Technologies and Global Markets

RNA Sequencing: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • March 2016
  • by BCC Research

This BCC Research report provides an overview of the current and future states of the RNA Sequencing (RNA Seq) market for the years 2015, 2016 and 2020 in segments such as instruments, tools and reagents, ...

Next-Generation Sequencing  Market by Platforms, Services, & Application - Global Forecasts to 2021

Next-Generation Sequencing Market by Platforms, Services, & Application - Global Forecasts to 2021

  • $ 4 650
  • Industry report
  • March 2016
  • by MarketsandMarkets

The global NGS market is expected to reach USD 10,371.1 million by 2021 from USD 4,031.7 million in 2016, at a CAGR of 20.8% between 2016 and 2021. North America is expected to hold the largest share of ...

Global Next Generation Sequencing (NGS) Market Growth, Trends & Forecasts (2015-2020)

Global Next Generation Sequencing (NGS) Market Growth, Trends & Forecasts (2015-2020)

  • $ 4 250
  • Industry report
  • January 2016
  • by Mordor Intelligence LLP

The Global market for Next Generation Sequencing is poised to reach $10 billion by the end of 2020 growing at a CAGR of approximately 20%. The instruments and consumables is the largest segment with a ...

The World Market For Microarrays

January 2016 $ 4 200

Cancer Markers

March 2016 $ 2 500

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.